| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse effects of tumour necrosis factor-α blocking agents
|
PARK, Kyung-Su
|
|
2006
|
9 |
2 |
p. 165-169
|
artikel
|
| 2 |
Anti-tumor necrosis factor therapy: the Australian experience
|
NASH, Peter
|
|
2006
|
9 |
2 |
p. 119-123
|
artikel
|
| 3 |
Anti-tumour necrosis factor-α: the dawn of a new era in the treatment of rheumatoid arthritis
|
|
|
2006
|
9 |
2 |
p. 103-104
|
artikel
|
| 4 |
A practical guide for the use of biologic agents in the treatment of rheumatoid arthritis*
|
|
|
2006
|
9 |
2 |
p. 123-126
|
artikel
|
| 5 |
Biologicals: educational needs in APLAR countries
|
|
|
2006
|
9 |
2 |
p. 105-106
|
artikel
|
| 6 |
Biological therapies for rheumatoid arthritis: beyond TNF-α blockade
|
MOK, Chi Chiu
|
|
2006
|
9 |
2 |
p. 200-205
|
artikel
|
| 7 |
Clinical experience with infliximab among Filipino patients with rheumatic diseases
|
NAVARRA, Sandra V.
|
|
2006
|
9 |
2 |
p. 150-156
|
artikel
|
| 8 |
Consensus on the use and monitoring of anti-TNF-α therapies for rheumatic diseases in Hong Kong 2005
|
|
|
2006
|
9 |
2 |
p. 175-180
|
artikel
|
| 9 |
Effectiveness of a modified dosing regimen with a lower maintenance dose of infliximab in the treatment of patients with ankylosing spondylitis and spondyloarthropathy
|
CHAN, K. Y.
|
|
2006
|
9 |
2 |
p. 131-135
|
artikel
|
| 10 |
Experience of antitumor necrosis factor-α therapies in Taiwan
|
James Cheng-Chung, WEI
|
|
2006
|
9 |
2 |
p. 161-164
|
artikel
|
| 11 |
Experience with anti-tumor necrosis factor-α therapy in India
|
KUMAR, Ashok
|
|
2006
|
9 |
2 |
p. 136-141
|
artikel
|
| 12 |
Extended indications for anti-tumor necrosis factor-α therapy
|
YOON, Chong-Hyeon
|
|
2006
|
9 |
2 |
p. 193-199
|
artikel
|
| 13 |
Guidelines for tuberculosis prophylaxis during anti-tumour necrosis factor-α treatment: Indian Rheumatology Association
|
HANDA, R.
|
|
2006
|
9 |
2 |
p. 181-183
|
artikel
|
| 14 |
Infliximab (Remicade®): from bench to clinical practice. A paradigm shift in rheumatology practice
|
HSIA, Elizabeth C.
|
|
2006
|
9 |
2 |
p. 107-118
|
artikel
|
| 15 |
Infliximab versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a preliminary study from China
|
ZHANG, Feng-Chun
|
|
2006
|
9 |
2 |
p. 127-130
|
artikel
|
| 16 |
Philippine guidelines on the screening for tuberculosis prior to the use of biologic agents
|
LICHAUCO, Juan Javier T.
|
|
2006
|
9 |
2 |
p. 184-192
|
artikel
|
| 17 |
Risk of tuberculosis in a Chinese registry of rheumatoid arthritis and ankylosing spondylitis for tumour necrosis factor-α antagonists
|
HUANG, Feng
|
|
2006
|
9 |
2 |
p. 170-174
|
artikel
|
| 18 |
The efficacy of infliximab for patients with rheumatoid arthritis in Japan: results of 5000 cases by post-marketing surveillance data
|
OKA, Hiroshi
|
|
2006
|
9 |
2 |
p. 142-145
|
artikel
|
| 19 |
The use of anti-tumour necrosis factor-α therapies for rheumatoid arthritis in Singapore
|
THONG, B. Y. H.
|
|
2006
|
9 |
2 |
p. 157-160
|
artikel
|
Tijdschrift beschrijving